Jan 17, 2020
This webinar will discuss treatment considerations for transitional-age youth with intellectual/developmental disabilities and co-morbid SMI. It will review the common co-morbid medical conditions in this population that can influence the choice in therapeutic agent, as well as the current evidence and guidelines available to guide clinical decision-making.
Rebecca McCloskey, PMHNP-BC, Boston Psychiatric Care
NAMI HelpLine is available M-F, 10 a.m. – 10 p.m. ET. Call 800-950-6264,
text “helpline” to 62640, or chat online. In a crisis, call or text 988 (24/7).